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Summary
 
The B cell receptor (BCR) triggers a variety of biological responses that differ depending upon
the properties of the antigen. A panel of M13 phage-displayed peptide ligands with varying af-
finity for the 3-83 antibody was generated to explore the role of antigen-BCR affinity in cell
activation studies using primary 3-83 transgenic mouse B cells. Multiple parameters of activa-
tion were measured. T cell–independent B cell proliferation, antibody secretion, induction of
germline immunoglobulin 
 
g
 
1 transcripts, and B cell production of interleukin (IL) 2 and inter-
feron 
 
g
 
 responses were better correlated with antigen-BCR affinity than with receptor occu-
pancy. In contrast, other responses, such as upregulation of major histocompatibility complex
class II and B7.2 (CD86), secretion of IL-6, and B cell proliferation in the context of CD40
signaling were only weakly dependent on antigen affinity. Biochemical analysis revealed that at
saturating ligand concentrations the ability of phage to stimulate some early signaling responses,
such as Ca
 
11
 
 mobilization and tyrosine phosphorylation of syk or Ig
 
a
 
, was highly affinity de-
pendent, whereas the ability to stimulate Lyn phosphorylation was less so. These data suggest
that the BCR is capable of differential signaling. The possibility that differential BCR signaling
by antigen determines whether an antibody response will be T independent or dependent is
discussed.
Key words: B lymphocytes • differential activation • phage library • immunoglobulin • trans-
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U
 
nlike growth factor, cytokine, or hormone receptors,
the B cell receptor (BCR)
 
1
 
 does not have a unique
ligand with predefined stereochemical and affinity charac-
teristics. This receptor can be stimulated by ligands of var-
ied affinity or stereochemical structure, and the ability to
distinguish among subtle differences may be an important
evolved specialization. B lymphocytes are able to respond
in a variety of ways to BCR engagement (1); for example,
antigen stimulation of mature B cells can lead to functional
inactivation (anergy), apoptosis, proliferation, and differen-
tiation to Ig secretion, or to the formation of a memory re-
sponse. Weak antigenic stimuli have even been postulated
to be required for resting B cell survival because induced
deletion of Ig H chain by cre/loxP-mediated recombina-
tion leads to rapid death of mature B cells (2). During the
generation of immune tolerance in the preimmune reper-
toire, immature B cells can similarly undergo a range of re-
sponses to antigen including receptor editing, death, or an-
ergy. It has also been suggested that very weak interactions
with antigens in immature sIgM
 
1
 
 cells can drive differenti-
ation to maturity (3–5). This complex differentiation po-
tential, which is induced through a single antigen receptor,
suggests an ability to integrate and interpret subtle differ-
ences in antigen structure.
Extensive in vitro studies using anti-IgM or anti-IgD an-
tibodies as surrogate antigens have analyzed the requirements
and steps of B lymphocyte activation (6–12). BCR-medi-
ated activation events in mature resting B cells include a
rapid tyrosine phosphorylation cascade apparently starting
 
1
 
Abbreviations used in this paper:
 
 BCR, B cell receptor; ITAM, immunoty-
rosine-based motifs; PVDF, polyvinylidene difluoride; trp, tryptophan. 
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within conserved immunotyrosine-based motifs (ITAM) of
the BCR signal transducer proteins Ig-
 
a
 
 and Ig-
 
b
 
 (13, 14).
This phosphorylation can be mediated by the Src family ki-
nase members lyn, blk, fyn, or fgr owing to the association
of some or all of these kinases with the nonligated receptor
(15, 16). Phosphorylation of conserved sites on Ig-
 
a
 
 or 
 
b
 
recruits and activates additional kinases, including syk,
which subsequently activate important downstream targets
(14, 17). Various tyrosine phosphorylations are believed to
recruit additional molecules involved in B cell signaling such
as phosphatidylinositol 3-kinase, phospholipase C-
 
g
 
2, and
Shc, which results in a propagation of signals, including
phosphoinositide metabolism, calcium mobilization, activa-
tion of protein kinase C and MAP kinase cascades, and tran-
scription factor activation (18–23). Sustained signaling stimu-
lates a variety of events in the nucleus resulting in enhanced
cell surface expression of MHC class II molecules and the T
cell costimulator B7.2 (CD86), and in some cases entry into
the cell cycle. Further signals regulate Ig secretion.
To initiate these events, BCR aggregation and a certain
level of BCR occupancy are required. Studies analyzing B
cell immune responses to T cell–independent antigens have
concluded that thresholds of antigen valence, epitope den-
sity, or epitope organization exist that must be exceeded in
order for a productive response to occur (24–27). Antigens
with structures that fail to satisfy these putative thresholds
can still provoke B cell immune responses, but these re-
quire T cell help. Similarly, thresholds of antigen structure
and B cell receptor occupancy are believed to control the
phenotype of immune tolerance (28). But the quantitative
relationships among antigen structure, biological response,
and intracellular signaling events have not yet been system-
atically studied in B cells.
The ability of antigen receptors to generate a range of
responses dependent on antigen/receptor affinity (or avid-
ity) has been intensively studied in T cells, which can re-
spond biologically in a variety of ways to ligands of subtly
differing structure. When presented in the peptide-binding
groove of MHC molecules, certain peptide ligands, termed
agonists, induce a robust proliferative response in mature T
cells. Slight modifications of the sequences of the agonist
peptides, which usually also lower affinity for the TCR,
can yield partial agonists peptides that fail to induce T cell
proliferation, but stimulate some biological activities, such
as specific lymphokine secretion (29). Altered peptide ligands
can sometimes also specifically antagonize T cell responses to
agonists (30, 31). Even remarkably low affinity interactions
can yield significant biological responses, such as the critical
positive selection step that regulates differentiation and sur-
vival of maturing thymocytes (32, 33). Biochemical analysis
indicates that these differential responses to ligands of very
low affinity are associated with partial signaling through the
TCR and associated molecules (18, 29, 34, 35).
To determine if B cells have a similar capacity for differ-
ential responsiveness and to understand the biochemistry of
these processes, we have taken advantage of two powerful
tools to evaluate BCR–ligand interactions. First, we have
used a homogeneous splenic B cell population isolated
from mice transgenic for genes encoding the 3-83 anti-
body, which was raised against the H-2K
 
k
 
 MHC class I
molecule (36). This B cell population is virtually mono-
clonal because the transgenic Ig mediates feedback suppres-
sion of endogenous Ig gene rearrangements (37). Second,
in order to characterize BCR stimulation by antigen in-
stead of anti-BCR antibodies, we have screened bacte-
riophage-displayed peptide libraries to identify alternative
ligands for the 3-83 antibody. These phages contain 12– or
15–amino acid peptide inserts in the pIII protein, which is
present in four copies per phage particle and is essential for
phage infectivity (38, 39). We have been able to isolate and
characterize phages that vary in their relative affinity for
3-83, but that are otherwise identical in valence and overall
structure, and therefore represent a useful system to com-
pare B lymphocyte activation based on affinity differences.
In this study, we use these reagents to test the hypothesis
that B cell receptors can mediate differential signaling.
 
Materials and Methods
 
Mice.
 
The 3-83 transgenic mice (36), which express IgM and
IgD forms of the 3-83 antibody, were bred and maintained in the
animal care facility at the National Jewish Center Medical and
Research Center. 3-83 mice were backcrossed a minimum of 10
times onto a B10.D2nSn/J background.
 
Phage-displayed Peptide Libraries.
 
Generation of the 12mer and
15mer libraries have been described previously (40). In brief, de-
generate oligonucleotides encoding the peptide insert sequences
and flanking restriction sites were annealed, cleaved with restric-
tion enzymes, purified, and ligated into the M13 DNA vector di-
gested with the same restriction enzymes: BglI for the 15mer li-
brary and XhoI/XbaI for the 12mer library. Ligation reactions
were electroporated into competent DH5
 
a
 
F
 
9
 
 bacteria, which
were mixed with top agar, poured onto petri plates and incubated
for 12 h at 37
 
8
 
C to allow plaque formation. The phage particles
were then recovered by diffusion into PBS that was added to the
surface of the plates and incubated 4 h at 4
 
8
 
C with gentle rocking.
After centrifugation at 4,000 rpm to remove contaminating bacte-
rial cells, phages were precipitated with polyethylene glycol/NaCl,
resuspended in PBS and used for subsequent affinity selection.
 
Selection of 3-83 Binding Phages from Phage-Displayed Peptide Li-
braries.
 
Library screenings were performed as previously de-
scribed (40). In brief, microtiter plate wells were coated with 10
 
m
 
g/ml of 3-83 antibody in 100 mM NaHCO
 
3
 
 for 3 h, then
blocked with a solution of 5 mg/ml BSA in 0.1 M NaHCO
 
3
 
 for
1 h. Approximately 5 
 
3
 
 10
 
11
 
 infectious particles were incubated
with the 3-83-coated wells in 50 
 
m
 
l PBS and 0.1% Tween 20 for
2 h. The wells were washed five times with PBS and 0.1%
Tween 20, and bound phages were eluted with 50 mM glycine
and HCl, pH 2.2, and neutralized with 50 
 
m
 
l of 200 mM sodium
phosphate, pH 7.4. Recovered phages were affinity selected two
more times as described above.
 
Large Scale Bacteriophage Purification.
 
Phages were purified us-
ing a modified version of a protocol described previously (41). In
brief, DH5
 
a
 
F
 
9
 
 competent cells were infected with phage and
grown overnight in 250 ml LB, 10 
 
m
 
g/ml kanamycin. After cen-
trifugation to remove bacteria, the supernatants were adjusted to
0.5 M NaCl, 5% polyethylene glycol 6000, and the phages were
allowed to precipitate overnight at 4
 
8
 
C. Phages were recovered
by centrifugation for 45 min at 8,000 rpm, and the pellet was re- 
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suspended in 10 ml of 0.01 M Tris-HCl, pH 7.6, 1 mM EDTA,
0.1% sarkosyl, and shaken slowly at room temperature for 30
min. The solution was adjusted to 0.5 M NaCl, 5% polyethylene
glycol and after 2 h at 4
 
8
 
C, the precipitated phages were recov-
ered by centrifugation for 1 h at 8,000 rpm. The pellet was resus-
pended in 10 ml of NET buffer (0.1 M NaCl, 1 mM EDTA, and
0.01 M Tris-HCl, pH 7.6), mixed well and the phage repelleted
by centrifugation at 15,000 rpm for 1 h. The phage pellet was fi-
nally resuspended in NET buffer and an OD at 260 nm reading
was taken to measure the phage concentration (1 OD unit 
 
5 
 
1
mg/ml of phage).
 
ELISA.
 
Culture supernatants were taken at the specified
time for each experiment. Analysis of 3-83 production was per-
formed using plates coated with 5 
 
m
 
g/ml of 54.1 rat anti-3-83 id-
iotypic antibody in PBS. After blocking with PBS containing
0.5% BSA, 0.4% Tween 20, supernatants at different dilutions
were incubated with the coated wells overnight. After several
washes, the wells were incubated with goat anti–mouse IgM cou-
pled to horseradish peroxidase (Southern Biotechnology Associ-
ates Inc., Birmingham, AL). Bound peroxidase was developed by
colorimetric substrate 2.2
 
9
 
-azino-di-3-ethyl-benzthiazoline-6-
sulfonic acid (Sigma Chemical Co., St. Louis, MO) in McIlvain’s
buffer (84 mM Na
 
2
 
PO
 
4
 
, 48 mM citrate, pH 4.6) containing
0.005% H
 
2
 
O
 
2
 
. The reactions were quantitated in an automated
plate reader at 410 nm with a reference wavelength of 490 nm
(Dynatech, Alexandria, VA). For 3-83 concentration, standard
curves were generated using a supernatant from Cos lin D1, an
Sp2/0 myeloma transfected with the 3-83 IgM heavy and light
chain genes.
 
Primary B Cell Purification.
 
Resting B lymphocytes were iso-
lated as previously described (42). In brief, spleens from 3-83
transgenic mice were removed aseptically and single cell suspen-
sions were prepared. Red blood cells were depleted by incuba-
tion for 5 min in Tris-ammonium chloride, pH 7.2, and T cell
depletion was done by incubating the cells with anti-Thy anti-
bodies (HO13.4.9 and T24/40) plus rabbit complement (GIBCO
BRL, Gaithersburg, MD) and 10 
 
m
 
g/ml DNAse (Sigma Chemi-
cal Co.) at 37
 
8
 
C for 45 min. The resting B cells were finally iso-
lated by centrifugation through Percoll at a density of 1.079 g/ml.
 
B Cell Culture.
 
Cells were cultured in 24-well plates at a final
concentration of 1 
 
3
 
 10
 
6
 
 cells/ml in IMDM 10% FCS, in the
presence of polymyxin B (Sigma Chemical Co.) at a concentra-
tion of 50 
 
m
 
g/ml. The phages were diluted to a concentration of
1 mg/ml in IMDM 10% FCS, passed through a 0.45-
 
m
 
m filter
and added to the cells at the specified final concentrations. The
anti-Fd antibody (Sigma Chemical Co.), which cross-reacts with
and cross-links M13 phage, was added to each well at a concen-
tration of 5 
 
m
 
g/ml. After various times of incubation, superna-
tants were analyzed for 3-83 IgM production and the cells were
stained for several cell surface markers. Proliferation was moni-
tored using the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetra-
zolium bromide (MTT) assay as described below. Anti-CD40 an-
tibody (a gift of Dr. Ton Rolink, Basel Institute for Immunology,
Basel, Switzerland) was added as supernatant of FGK45 hybri-
doma culture, at 100 
 
m
 
l per 10
 
6
 
 spleen cells.
 
Flow Cytometry.
 
5 
 
3
 
 10
 
5
 
 cells were stained on ice for 20 min
with the indicated antibodies in PBS supplemented with 1%
BSA, 0.02% NaN
 
3
 
. The following antibody reagents were used:
mouse anti-IgM-FITC (Zymed Laboratories, Inc., South San
Francisco, CA), mouse anti-I-A
 
d
 
–FITC (PharMingen, San Di-
ego, CA), mouse anti-B220-PE (Caltag Laboratories, Burlingame,
CA), biotin-54.1, biotin-anti-B7.2 (PharMingen), or biotin-anti-
IgD (PharMingen). After two washes, cells were incubated with
 
streptavidin-tri-Color (Caltag) for 20 min on ice to visualize
bound biotinylated antibodies, then washed twice and fixed in a
solution of PBS/2% paraformaldehyde. Flow cytometric analysis
was done using a FACScan
 
Ò
 
 (Becton Dickinson & Co.) and the
data analyzed using the Cell Quest software.
 
PCR Assay.
 
RNA isolation using RNazol B (Tel-Test,
Friendsville, TX), cDNA first strand synthesis, and G
 
a
 
S PCR
were carried out as previously described (37). The 
 
g
 
1 switching
transcript PCR assay was as described in (43).
 
RNase Protection Assay.
 
The RiboQuant kit (PharMingen)
was used for this assay with the mCK-1 probe set, according to
the protocol recommended by the manufacturer. 7 
 
3
 
 10
 
6
 
 puri-
fied B cells were stimulated for 3 or 6 h in presence of 500 
 
m
 
g of
the various phages and 5 
 
m
 
g/ml anti-Fd antibody (Sigma Chemi-
cal Co.). RNA was isolated using RNazol B (Tel-Test), and used
for RNase protection assay.
 
Cytokine Staining.
 
3-83 splenic cells were stimulated 4 h with
Pwt or P31 phage and stained first with B220-PE antibody (Cal-
tag) then stained intracellularly in presence of 0.3% saponin with
anti-IFN-
 
g
 
–FITC, anti-IL-2–FITC, Rat IgG1–FITC (PharMin-
gen) or anti-IgM–FITC (Zymed Laboratories, Inc.). After several
washes in presence of saponin 0.1%, the cells were placed on
poly-
 
D
 
-lysine (Sigma Chemical Co.) coated cover slips, fixed
with 1% paraformaldehyde in PBS, mounted and analyzed with a
100
 
3
 
 planApo 1.4 oil objective using a Nikon microscope. Pho-
tos were taken using a Photometric camera and IPlab software
(Signal Analytics Co., Vienna, VA).
 
Calcium Mobilization Analysis.
 
For measurement of intracellu-
lar free calcium, K46J (1 
 
3
 
 10
 
6
 
 cells/ml) cells were loaded with
Indo-1 AM (Molecular Probes, Inc., Eugene, OR) and subse-
quently stimulated with either a mouse anti-Ig 
 
k
 
 antibody
(Southern Biotechnology Associates Inc., Birmingham, AL) or
with various concentrations of the different phage followed as
specified by anti-Fd antibody (Sigma Chemical Co.). Calcium
mobilization was monitored by flow cytometry for 10–15 min
(Cytofluorograf 30/50; Ortho Diagnostic Systems, Westwood,
MA). The percent of responding cells and the 490/390 nm mean
ratio were calculated using the MultiTime software (Phoenix
Flow Systems, San Diego, CA).
 
Phosphotyrosine, Immunoprecipitation, and Immunoblot Analysis.
 
3-83 primary B cells (3 
 
3
 
 10
 
6
 
 cells) were stimulated for various
amounts of time at 37
 
8
 
C with goat anti–mouse IgM antibody
(Southern Biotechnology Associates Inc.) or one of the phage
preparations followed by cross-linking with anti-Fd antibody
(Sigma Chemical Co.). Cells were lysed in 1% NP-40 lysis buffer
(1% NP-40, 150 mM NaCl, 10 mM Tris-HCl, pH 7.4, 2 mM
sodium orthovanadate, 10 mM sodium pyrophosphate, 0.4 mM
EDTA, 10 mM NaF, 1 mM phenylmethylsulfonyl fluoride, and 2
 
m
 
g/ml each of aprotinin, leupeptin, and 
 
a
 
-1-antitrypsin) and
centrifuged for 10 min at 14,000 rpm to remove detergent-insol-
uble material. Supernatants were then mixed with SDS reducing
buffer. Whole cell lysates were fractionated on 10% SDS-PAGE
and transferred to polyvinylidene difluoride (PVDF) membrane.
Anti-phosphotyrosine immunoblotting was carried out by incu-
bating the membrane with the Ab2 antibody (Calbiochem Nova-
biochem Corp., La Jolla, CA) in 5% BSA in TBS (10 mM Tris-
HCl, pH 8.0, 150 mM NaCl) for 2 h at 25
 
8
 
C, followed by rat
anti–mouse IgG coupled to horseradish peroxidase (Zymed Lab-
oratories, Inc.) in 5% milk in TBS for 1 h at 25
 
8
 
C. The blot was
then developed using ECL system (Amersham Pharmacia Biotech
Inc., Piscataway, NJ).
Immunoprecipitations of Syk, Lyn, and Ig
 
a
 
 were performed
on lysates of 9 
 
3
 
 10
 
6
 
 cells using 5–10 
 
m
 
g of affinity-purified anti- 
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bodies coupled to Sepharose beads. Immunoprecipitates were
washed three times in lysis buffer, resuspended in 50 
 
m
 
l of reduc-
ing SDS-PAGE sample buffer, then fractionated using 10% SDS-
PAGE gels. Electrophoretically fractionated proteins were trans-
ferred to PVDF membranes which were then treated as described
above.
 
Results
 
Identification of Alternative Ligands for the 3-83 Antibody.
 
Two M13 phage-display random peptide libraries contain-
ing either 15mer or 12mer insert peptides were screened
for phages that bound to the 3-83 antibody. This led to the
isolation of a single phage bearing a 15mer peptide and 13
unique phages containing 12mer inserted peptides. The in-
serted peptide sequences of affinity selected phages are
listed in Fig. 1 
 
A
 
. The isolated phages bound specifically to
the 3-83 heavy plus light chain combination, but not to
isotype-matched antibodies or other antibodies bearing
similar light or heavy chains (data not shown). Thus, these
phages most likely bind to the 3-83 antigen binding site.
Homology searches of GENBANK did not reveal any
similarities between these peptide sequences and any MHC
genes. None of the 12mer sequences matched any known
database sequences. Comparison of the 12mer peptide se-
quences to each other allowed us to identify three motifs
(Fig. 1 
 
A
 
, 
 
boxed sequences
 
). The first motif, asn-trp-asn-xxx-
val/leu-gln, was found in five sequences at various posi-
tions within the peptide, whereas the remaining amino ac-
ids in the peptides appeared to be totally unrelated. The
second motif, pro-gly-gly-trp-gln-xxx-xxx-trp, was found
at different positions in two peptides. Again, the amino ac-
ids outside the motif were distinct. The last motif, gln-asp-
tyr, was likewise found in two sequences, but in this case at
the same position within the peptides. Collectively, these
data reveal that it is possible to identify linear epitopes that
bind to an antibody known to recognize a conformational
epitope, and that many linear epitopes specific for 3-83 can
be found that possess almost no sequence similarities among
themselves or with the initial immunogen.
 
Recombinant Phages Bind to the 3-83 Antibody with Differing
Relative Affinities.
 
To define among the selected phages
(Fig. 1 
 
A
 
) ligands with distinct affinities for the 3-83 anti-
body, we measured phage binding in solid phase ELISA
using plate-bound 3-83 antibody (Fig. 1 B) or in binding
assays to 3-83-bearing B cells (Fig. 1 C). The 15mer pep-
tide-bearing phage P31 had the highest affinity for 3-83,
whereas the 12mer-bearing phages exhibited a wide range
of affinities (data not shown). Four representative phages
were chosen for detailed analysis: P31, which has the high-
est relative affinity, P11 with the lowest relative affinity,
and P5 and P7, which possess intermediate affinities for the
3-83 antibody. P5 and P7 binding to 3-831 B cells was in-
hibited by a synthetic peptide containing the P31 sequence,
indicating that P31, P5, and P7, bind to the same region of
the 3-83 Ig (data not shown). A phage lacking a peptide in-
sert, Pwt, was used as a negative control in all the experi-
ments. Thus, phages of differing relative affinity to the 3-83
BCR were identified for detailed studies of B cell activa-
tion.
Recombinant Phages Can Induce Full or Partial B Cell Acti-
vation In Vitro. To test if the variable affinities of the phage
ligands for 3-83 had any relevance to B cell activation, we
analyzed the biological effects of interaction between
phages and B lymphocytes in short term cultures. Splenic B
cells from 3-83 Tg mice were stimulated with a broad
range of concentrations (0.2–100 mg/ml) of highly purified
phages. Concentrations .50 mg/ml are saturating for all
the phages (Fig. 1 C). As the phages tend by nature to par-
tially aggregate, they were incubated with cells in the pres-
ence of anti-phage antibody to promote extensive and uni-
form cross-linking. After 72 h of culture, cell count,
proliferation, and blastogenesis were monitored for each
culture condition. P31 was able to induce strong cellular
proliferation (Fig. 2 A), whereas P5 induced only a very
modest proliferation at the highest concentration. No pro-
Figure 1. 3-83 peptide ligands isolated from phage-display libraries. (A)
Peptide sequences inserted into the PIII minor coat protein of M13
phages isolated by affinity purification with the 3-83 antibody are shown.
The shadowed boxes highlight the common motifs found in the 12mer
peptides. Designations of the phages referred to elsewhere in the text are
shown at left. (B) ELISA binding analysis of the relative affinities of phages
named P31, P5, P7, and P11. Serial dilutions of each purified phage were
reacted with 3-83 Ig–coated plates and revealed with an anti-bacterio-
phage Fd-HRP. Pwt phage, which contains no inserted peptide, was used
as a control to account for nonspecific background. (C) Relative binding
of the various phages to 3-83 splenic B cells. 3-83 spleen cells were
stained with B220-PE antibody and decreasing amount of the different
peptide expressing-phages, which were revealed with anti-Fd antibody
followed by goat anti–rabbit FITC antibody. Mean fluorescence inten-
sities were measured on gated B2201 cells. Data shown are representative
of several experiments.1457 Kouskoff et al.
liferation was observed with P7 or P11 phages (Fig. 2 A),
even at concentrations that saturated the BCR (Fig. 1 C).
The absolute number of B2201 cells recovered at the end
of culture correlated well with the proliferative response, as
only P31-stimulated cultures demonstrated an increase in B
cell recovery over input (data not shown). After 72 h of
culture with P31, and to a lesser extent with P5 and P7, B
lymphocytes were in a blasting state as shown by their in-
creased forward light scatter characteristics (Fig. 2 B),
whereas no blastogenesis was observed when B cells were
cultured with Pwt or with receptor saturating amounts of
the low affinity phage, P11.
An important marker of B cell differentiation is the pro-
duction of germline Ig constant region heavy chain
mRNA, which precedes heavy chain gene class switching
(43). P31, P5, and P7 were all able to stimulate transcrip-
tion of the germline g1 locus, whereas neither P11 nor LPS
were able to do so (Fig. 2 C).
The ability of 3-83-binding phages to stimulate B cell ef-
fector function, i.e., antibody secretion, was tested (Fig. 2
D). Significant 3-83 IgM secretion was detected in cultures
stimulated for 72 h by P31 or LPS, whereas none of the
other 3-83-binding phages was able to induce a significant
level of 3-83 production over that induced by Pwt. IgM
secretion was also measured as a function of increasing con-
centrations of phage: both P5 and P7 induced a response at
a concentration of 100 mg/ml, but it never reached the
level of response observed with P31, which could be in-
duced with concentrations as low as 2 mg/ml (data not
shown). BCR saturating concentrations of P11 never in-
duced a significant response, despite its ability to bind the
BCR (Fig. 2 D).
Collectively, these data indicate that the levels of B cell
proliferation, T cell independent antibody secretion, and
initiation of class switching correlate with the relative affin-
ity of the BCR for its ligand, rather than with BCR occu-
pancy. P31 was able to induce full stimulation of 3-831 B
cells, whereas P5 and P7 phages were able to induce only
partial activation responses, as indicated by blastogenesis
and production of sterile g1 transcripts.
Peptide-Expressing Phages Induce Differing Patterns of Lym-
phokine Expression. We tested the ability of the various
phages to stimulate lymphokine gene expression in purified
resting 3-83 B cells both because lymphokines have potent
biological effects and because partial T cell agonists can in-
duce lymphokine secretion, but not cell proliferation. After
3 and 6 h of phage stimulation, mRNA levels in the B cells
was analyzed by RNase protection assays using a large set
Figure 2. 3-83 Ig affinity for peptide-expressing phages partially correlates with the degree of in vitro B cell activation. 3-83 transgenic spleen cells
were cultured in the presence of increasing concentrations of the various phage or with 10 mg/ml LPS. After 72 h, (A) cell viability and proliferation was
assessed using a MTT assay. Proliferation data are mean 6 SD from triplicate wells. (B) Forward size scatter of cells stimulated with phage at 100 mg/ml
was analyzed by flow cytometry. Data shown come from the B2201 gated population and are representative of 5 independent experiments. (C) Germline
g1 transcripts were analyzed by RT-PCR on RNA from cells stimulated 48 h with phage at 100 mg/ml. GaS PCR was used as an internal control. Data
shown are representative of four different experiments. (D) Supernatants of splenic stimulated-cultures were tested by ELISA after 24, 48, and 72 h of
stimulation. Serial dilutions of each supernatant were reacted on 54.1 antibody (3-83 anti-idiotype)-coated plates and revealed with either an anti-IgM or
an anti-k antibody. Data shown represent one of several experiments for the 48- and 72-h time points. Supernatant from cultures stimulated with LPS (20
mg/ml) was used as a positive control of Ig production.1458 Differential Activation of B Lymphocytes
of lymphokine probes. No antigen-induced changes were
detected in the levels of the following mRNAs: IL-4, IL-5,
IL-9, IL-10, IL-13, and IL-15. Little induction could be
seen in any of the samples at the 3-h timepoint (data not
shown). But after 6 h of stimulation with P31, a clear in-
crease in mRNAs was observed for IL-6, IL-2, and IFN-g
(Fig. 3, A and C). P5 was able to induce a similar pattern of
lymphokine mRNA upregulation, however, IL-2 and
IFN-g transcription was stimulated to a slightly lower level
than with P31. By contrast, P7 and P11 stimulation only
increased IL-6 mRNA levels and failed to stimulate IL-2
and IFN-g transcription (Fig. 3, A and C). The rise in IL-2
and IFN-g mRNA in P31- or P5-induced cultures was not
likely the result of T cell activation, as the cell preparations
were virtually devoid of T cells as a result of the specific
depletion of Thy 11 cells (Fig. 3 B); in addition experi-
ments using whole spleen cells resulted in lower signals
than in the purified B cell cultures (not shown). However,
to rule out the possibility that the observed mRNA upreg-
ulation might have been the indirect activation of contami-
nating non-B cells, total splenic cells were costained for
B220 and IL-2 or IFN-g after 4 h of stimulation with P31
or Pwt (Fig. 4). About 5% of the P31-stimulated cells co-
stained for B220 and IL-2 or IFN-g, whereas no brightly
stained cells were observed upon staining with an isotype
control antibody. Furthermore, no B220/IFN-g or B220/
IL-2 costained cells were observed in Pwt stimulated cul-
tures (data not shown). The low percentage of B cells ex-
pressing IL-2 or IFN-g seemed to indicate a transient state
of lymphokine production and correlated well with the
low level of mRNA expression detected in RNase protec-
tion assay (Fig. 3). B cells are reported to be capable of pro-
ducing IL-2, IL-6, and IFN-g (44–48), but the ability of B
cells to secrete IL-2 and IFN-g is not widely accepted.
Only P31 and P5 were able to upregulate IL-2 and IFN-g,
whereas all of the 3-83-binding phage induced an increase
IL-6 mRNA. These data strongly suggest that the various
phages induce qualitatively distinct lymphokine expression
responses based on BCR-ligand affinity rather than on re-
ceptor occupancy.
All Recombinant 3-83 Binding Phages Were Able to Initiate
Signs of T-dependent Response In Vitro. After 24 h of cul-
ture at saturating phage concentration, B cells were ana-
lyzed for expression of surface proteins known to be upreg-
ulated early during activation (Fig. 5, A and B). The
relatively high basal MHC class II I-A protein expression
was specifically increased 1.5–2-fold on B cells cultured
with all of the 3-83 reactive phage, but not with Pwt. Ex-
pression of B7.2 (CD86), which is involved in costimula-
tion during B-T interactions (49, 50), was increased from
undetectable levels to fluorescence levels that were two- to
threefold above background upon interaction with P31,
P5, and P7 phage, whereas P11 induced a lower (1.3-fold),
but consistent stimulation of B7.2 expression. The ability
of phage stimulation to downmodulate sIgM and sIgD lev-
els was also measured using a flow cytometry assay (Fig. 5
B). Like the induction of MHC class II and B7.2 mole-
cules, Ig internalization of its ligand is important for B cell
antigen presentation to T cells. The high affinity phage P31
markedly downregulated sIgM and sIgD cell surface ex-
pression, whereas the lower affinity phages P5, P7, or P11
only modestly downmodulated sIgM and sIgD (Fig. 5 B).
Figure 3. RNase protection assay reveals differential lymphokine ex-
pression patterns induced by the various phages. (A) RNA isolated from
purified 3-83 primary B cells stimulated for 6 h with 100 mg phage was
assayed for RNase protection using the multilymphokine mCK-1 probe.
GAPDH mRNA served as an internal control of RNA input. (B) Cells
were stained with anti CD4-PE and anti CD8-FITC before and after B
cell purification to monitor the extent of residual T cell contamination.
(C) Quantitation of lymphokine gene mRNA levels. Mean 6 SD of five
independent experiments. After densitometry analysis on an Eagle III eye
apparatus (Stratagene), the ratio between the GAPDH and the lympho-
kine signals were calculated for each phage.
Figure 4. Intracellular staining
of B lymphocytes for IL-2 and
IFN-g cytokines. After 4 h of
stimulation with P31 at 100 mg/
ml, 3-831 splenic cells were
stained with B220-PE ab and anti-
IgM–FITC, anti-IFN-g–FITC,
anti-IL-2–FITC or Rat IgG1/k–
FITC. Data shown are representa-
tive of six independent experi-
ments.1459 Kouskoff et al.
Phage binding failed to directly inhibit staining with anti-
IgM and anti-IgD antibodies (data not shown) indicating
that specific phage binding actively induced the down
modulation of these molecules.
To determine if the 3-83-binding phages that were not
directly mitogenic could induce B cell proliferation in con-
ditions that mimic T cell help, we tested their ability to
promote growth in synergy with anti-CD40 antibody (Fig.
5 C). 3-83 splenic cells were cultured with subsaturating
concentration of phage (20 mg/ml), without anti-Fd cross-
linking antibody, in the presence or absence of an agonistic
anti-CD40. Engagement of the CD40 molecule on B lym-
phocytes, alone or in the presence of Pwt, induced some
proliferation, as expected from prior studies (51). Impor-
tantly, in the presence of anti-CD40 all of the 3-83 binding
phages induced significant augmentation in proliferation
(Fig. 5 C). Flow cytometry analysis with B cell markers
confirmed the specific increase and blasting state of the B
cell population (data not shown).
These data demonstrate that, regardless of their affinity
for the BCR, all of the 3-83-binding phages were able to
increase the expression of MHC class II, CD86, and IL-6,
and to stimulate B cell proliferation in presence of anti-
CD40 antibody. Thus, some B cell activation responses are
not strongly affected by the affinity of the BCR for its
ligand. Interestingly, this subset of responses is associated
with the T cell–dependent B cell response.
Phage-Induced Ca11 Mobilization Is Affinity Dependent.
That the 3-83-reactive phages induced distinct and repro-
ducible biological responses prompted us to test if these re-
sponses were correlated with early signaling events. The abil-
ity of the phages to mobilize calcium upon BCR signaling
was tested using a transfectant of the K46 B cell lymphoma
expressing the 3-83 BCR, K46J (42, 52). As expected, the
high affinity phage P31 induced a significant calcium flux
(Fig. 6 A), but this response differed in several ways from the
response elicited by anti-Ig k. The initial peak of Ca11 in-
duced by the anti-k treatment, which represents primarily a
mobilization of the intracellular stores (53), was absent or
very weak in the P31-induced response, and the anti-k re-
sponse was stronger than the P31 response both in terms of
the percentage of responding cells and the level of calcium
mobilized (Fig. 6 B). Neither increasing the dose of phage
P31, nor cross-linking with an anti-phage antibody pro-
voked an increase in the response above a certain plateau,
which in the absence of cross-linking was reached with 40
mg of phage per 2 3 105 cells (data not shown). P5, P7, and
P11 all induced a weak calcium mobilization at BCR satu-
rating concentrations (Fig. 6 B). Thus, the extent of calcium
mobilization induced by the phages corresponded to their
relative affinities for the 3-83 BCR and was distinct from the
response induced by anti-BCR antibodies.
Affinity-dependent Induction of Differential Patterns of Syk
and Lyn Phosphorylation in Primary B Cells. To further char-
acterize the correlation between biological response and
BCR signaling, we investigated induction of protein-
tyrosine phosphorylation in purified splenic resting 3-83 B
cells stimulated with the panel of phages. P31 induced the
rapid phosphorylation of many proteins in a pattern similar
to that observed with anti-IgM stimulation (Fig. 7),
whereas the control Pwt did not induce any tyrosine phos-
phorylation over the background detected in unstimulated
cells. P31 induced a strong pattern of protein-tyrosine
phosphorylation over a wide concentration range; subsatu-
rating concentrations as low as 0.3 mg/106 cells were still
able to induce significant tyrosine phosphorylation (Fig. 7).
Intermediate affinity phage P5 induced a pattern of pro-
tein-tyrosine phosphorylation that was similar to, but
weaker, than that achieved with P31 (Fig. 8 A). Saturating
concentrations of P7 or P11 induced a very limited and
weak pattern of phosphorylation (with the possible excep-
tion of a high molecular weight species, indicated by an ar-
Figure 5. Ability of phages to induce signs of T-dependent response in
vitro. (A) Surface expression of B7.2 and class II markers was assessed by
immunofluorescence staining on cells stimulated with phages at 100 mg/
ml. (B) The mean surface expression of the indicated markers on B cells
stimulated with the various phage expressed relative to the expression lev-
els of cells cultured with Pwt. For all markers analyzed, the mean fluores-
cence intensity was measured on the B2201 gated population, after 24 h
of stimulation. Data shown represent a mean average 6 SD of four inde-
pendent experiments. (C) 3-83 transgenic spleen cells were stimulated
with the various phage at 20 mg/ml in absence of anti-Fd cross-linking
ab, with or without anti-CD40 ab. Proliferation was assessed using a
MTT assay at 24, 48, and 72 h of stimulation. Data are mean 6 SD from
triplicate wells from three independent experiments.1460 Differential Activation of B Lymphocytes
row; Fig. 8 A). No changes or increases were observed in a
30-min time course stimulation for any of the low affinity
phages (data not shown).
P31 induced the tyrosine phosphorylation of Iga, Lyn,
and Syk as identified by specific immunoprecipitation (Fig.
8 B). Upon stimulation with P5, both Lyn and Syk became
phosphorylated, but to a lesser extent than with high affin-
ity phage, whereas Iga was not detectably phosphorylated.
P7 and P11 induced the phosphorylation of Lyn to a level
equivalent to that of P5, but failed to detectably phosphor-
ylate Iga or Syk (Fig. 8 B). These data reveal differential
induction of tyrosine phosphorylation by the various
ligands. High affinity phage P31 induced a full and robust
pattern of response, P5 induced phosphorylation of Lyn,
weak phosphorylation of Syk, and no Iga phosphorylation,
whereas P7 and P11 were able to stimulate phosphor-
ylation of Lyn in the absence of tangible Iga and Syk phos-
phorylation. Thus, these early tyrosine phosphorylation
events were not strictly dependent upon BCR occupancy,
but were more closely correlated with ligand-BCR affinity
and later biological responses.
Discussion
It is important to develop reproducible techniques to an-
alyze antigen receptor responses to weak ligands because
there is increasing evidence that these responses are both
biologically significant, and biologically distinct, from re-
sponses to strong ligands. To more precisely assess the rela-
tionship between BCR-ligand affinity and its functional
consequences on B cell activation, we have isolated several
phage-bound peptide ligands that possess a wide range of
relative affinities for a particular BCR, but are otherwise
Figure 6. Calcium mobilization induced by the peptide-expressing
phage ligands. For each assay, K46J cells loaded with Indo-1 AM were run
on a Cytofluorograf 30/50 (Ortho Diagnostic Systems) to define a base
line of 490/390 ratio which is a direct measurement of calcium concen-
tration. (A) After 2 min, a stimulus (indicated by the arrow) was added,
either 2 mg of anti-k antibody as a positive control, or 80 mg of Pwt or
P31 phage, and the 490/390 ratio modification was followed over a 10-
min period. Data shown is representative of five independent experi-
ments. (B) This assay was repeated for the various phage, and the mean
490/390 ratio and the percentage of responding cells were calculated us-
ing the MultiTime software (Phoenix Flow Systems). The data presented
are mean values 6 SD of four experiments.
Figure 7. The high affinity phage P31 induces a strong pattern of ty-
rosine phosphorylation. Whole cell lysates were prepared from 3-83 pri-
mary B cells 5 min after stimulation with 3 mg of anti-IgM antibody, 60
mg of Pwt phage, or with the indicated amount of P31 phage. Samples
were fractionated on an SDS-PAGE and after transfer to a PVDF mem-
brane, the phosphotyrosine-containing proteins were detected with the
Ab2 antibody.
Figure 8. Differential tyrosine
phosphorylation pattern induced
by peptide-expressing phage of
varying affinities. (A) Whole cell
lysates were prepared from 3-83
primary B cells 5 min after stim-
ulation with 3 mg of anti-IgM or
with 60 mg phage. Samples were
loaded on an SDS-PAGE, trans-
ferred to a PVDF membrane,
and the phosphotyrosine-con-
taining proteins were detected
with the Ab2 antibody. (B) Im-
munoprecipitations of Syk, Lyn,
and Iga were performed on ly-
sates of 1.2 3 107 stimulated cells
using 5–10 mg of affinity-puri-
fied Ab coupled to Sepharose
beads. Electrophoretically frac-
tionated proteins were trans-
ferred to PVDF membrane and
revealed using the indicated anti-
bodies. Data shown are represen-
tative of three independent ex-
periments.1461 Kouskoff et al.
comparable in overall structure and valence, and used them
to stimulate specific primary B cells. These peptide-expres-
sing phages are relatively easy to produce and provide
highly specific, reproducible reagents for the analysis of an-
tigen receptor signaling. We find in this study that B lym-
phocyte activation is better correlated with the strength of
the BCR-ligand interaction than with receptor occupancy.
This differential induction was observed in the early signal-
ing events of tyrosine phosphorylation and Ca11 mobiliza-
tion, as well as at the level of lymphokine gene transcription,
cell surface marker modulation, blastogenesis, proliferation,
and antibody production (Table 1). The responses of 3-83
B cells stimulated by phage-bound ligands fell into distinct
categories depending upon the stimulus. The differences
observed between P31 and P11 in their ability to stimulate
B cells also appear to be relevant in vivo as P11, but not
P31, induced secondary light chain rearrangement in the
peripheral lymphoid organs of immunized 3-83 transgenic
mice (54). Collectively, these data suggest the existence of
weak and partial BCR agonists, as some of the peptide
ligands identified seem to stimulate only some, but not all
of the responses induced by a full agonist. These results fur-
ther suggest that, like the T cell receptor, the BCR pos-
sesses the capacity for differential or partial signaling.
Although the responses we observed are correlated with
affinity, this correlation is not perfect and affinity might not
be the most critical parameter influencing the observed re-
sponses. The two intermediate affinity phages, P5 and P7,
have a very similar relative affinity for 3-83, but are distinct
in terms of their ability to induce lymphokine gene tran-
scription and tyrosine phosphorylation, even at receptor
saturating concentrations (Table 1). It is conceivable that it
is not the equilibrium affinity but the on or off rate of the
BCR-ligand interaction that determines the outcome of
activation responses, if, for example, ligands with rapid dis-
sociation rates could not trigger the BCR for a long
enough period of time to induce a full range of effects. The
duration of receptor occupancy is thought to play an im-
portant role in the differential signaling of the TCR (55–
57). Alternatively, the phage ligands may differ in their
ability to induce a critical conformational change in the re-
ceptor. Because of the relative simplicity of the BCR-anti-
gen interaction compared with TCR-antigen interactions,
our experimental system may provide advantages in ap-
proaching the biochemistry of differential antigen receptor
signaling.
Some of the biological effects induced by the high affin-
ity phage P31, such as blastogenesis and antibody produc-
tion, were also reproduced using 3-83 transgenic RAG-
deficient spleen cells (data not shown), which are totally
devoid of T lymphocytes because the RAG mutation pre-
cludes any rearrangement of the TCR-a, -b, -g, and -d
loci (58). These data indicate that the B cell response in-
duced by P31 is fully T cell independent. The dependence
of this response on cross-linking with anti-phage antibodies
also points to a T-independent type response, which is
known to require a high level of BCR cross-linking (26).
The observed distinctions between agonist and partial ago-
nist ligands documented in this study apply to a T-inde-
pendent response and may be different in the context of T
cell dependent responses. It is probably significant that even
the lowest affinity 3-83-binding phage was able to stimu-
late proliferation in presence of anti-CD40 and to upregu-
late B cell expression of B7.2 and MHC class II molecules
because these molecules are critical for stimulatory interac-
tions with T cells. The ability of BCR ligands to act as full
rather than partial agonists might play an important role, in
vivo, in initiating T-independent rather than T-dependent
B cell responses. Furthermore, the observed production by
B cells of IFN-g and IL-2 in response to the two highest
affinity phages might represent an autocrine pathway al-
lowing for T cell–independent survival, differentiation, or
growth.
We describe the isolation and characterization of several
peptide ligands for the 3-83 antibody, which was originally
raised against a conformational determinant on the poly-
morphic a1-a2 domains of particular MHC class I mole-
cules (59). None of the peptide sequences share homology
Table 1. Summary of the Responses Induced by the Various Phage
Binding by
ELISA
Syk Lyn
Calcium
Lymphokine 
transcription
Downreg-
ulation Upregulation
g1
transcript
3.83 pro-
duction Phage phosphorylation IL-2 IL-6 IFN-g IgM IgD B7.2 Class II
P31 agonist 111 11 11 11 11 11 11 11 11 11 11 1 11
P5 weak agonist 11 1 1 1 1 11 1 1 1 11 11 1 6
P7 partial agonist 11 2 1 6 2 11 2 1 1 11 11 1 6
P11 partial agonist 12 1 6 2 1 1 2 1 1 1 1 1 2 2
Pwt 22 2 2 2 2 2 2 2 2 22 21462 Differential Activation of B Lymphocytes
with MHC genes. Although binding motifs can be seen
among some of the peptides (Fig. 1 A), examination of the
sequences reveals that the 3-83 antibody can bind to a vari-
ety of structures. A surprising feature of the 3-83-binding
peptides is the high representation of tryptophan (trp) resi-
dues. Among the identified peptides, eight sequences con-
tain one trp residue, four peptides contain two, one peptide
contains three, whereas only one does not contain trp. This
is probably not due to a bias in the libraries since in both li-
braries each amino acid is randomly encoded using the N/
N/(C or G) coding scheme, where N represents an
equimolar mixture of the four deoxyribonucleotides (40).
Furthermore, mutational analysis of the 15mer peptide in-
dicated that trp at position 3 was critical for 3-83 binding
(unpublished data). A major conclusion to be drawn is that
a wide variety of short linear peptides are capable of mim-
icking a conformational antigenic determinant, albeit with
a wide range of affinities. The phage library approach has
been shown to be effective in isolating surrogate ligands to
many types of receptors and proteins (38, 60–63). Our
study further extends these findings to demonstrate that
many such surrogate ligands potentially exist and can in-
duce functionally distinct signals to reactive B cells.
The fact that an enormous diversity of peptide sequences
can functionally interact with a particular BCR has impor-
tant theoretical and practical implications. First, it implies
that antibody cross-reactivity to unrelated antigens is un-
avoidable. Second, it suggests that antigenic mimicry by
microbes could often promote autoimmunity and that such
mimicry may be independent of amino acid sequence simi-
larity. Third, it suggests that cross-reactivity must pose an
important problem for immune self-tolerance at multiple
stages in B cell development. For T lymphocytes, it has
been proposed that the potential problems caused by this
broad cross-reactivity may be partly mitigated by the fact
that the more numerous, low affinity interactions can be
antagonistic. It remains to be seen to what extent B cell-
ligand antagonism can occur.
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